Skip to main content
    H

    Harte Hanks Inc (HHS)

    Official site

    INDUSTRIALS • CONGLOMERATES • NASDAQ

    $3.85
    -0.16 (-3.99%)

    Market Cap: $29.89M

    Last updated: Nov 17, 2026 at 10:25 AM ET

    Harte Hanks Inc (HHS) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Harte Hanks (HHS) trades at 0.2x sales and 2.0x book value. Its P/S of 0.2x is in line with its 5-year median. Its forward P/E is 14.3x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/E14.3x
    Price to sales0.2x
    Price to book2.0x
    PEGN/A
    FCF yield-34.4%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is in line.

    MultipleCurrent5-year median10-year median
    P/S0.2x0.2x0.2x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 98 months (10-year).

    Valuation History

    Over the 5 of the 10 year ends shown that have a P/E, its P/E ranged from 2.6x in 2022 to 12.3x in 2023.

    Year endPriceP/EP/SP/B
    2025$3.01N/A0.1x1.1x
    2024$5.154.4x0.2x1.7x
    2023$6.7912.3x0.3x2.5x
    2022$11.692.6x0.4x4.6x
    2021$7.606.3x0.3xN/A
    2020$2.754.4x0.1xN/A
    2019$3.58N/A0.1xN/A
    2018$2.42N/AN/AN/A
    2017$9.50N/A0.2xN/A
    2016$15.10N/A0.2x34.1x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About HHS

    What is HHS's forward P/E ratio?

    Harte Hanks has a forward P/E ratio of 14.3x.

    Is HHS stock overvalued?

    GNG's valuation label for HHS is Undervalued.

    What is HHS's price to sales ratio?

    Harte Hanks has a price to sales ratio of 0.2x.